RARA and acute promyelocytic leukemia: RARA has been implicated as a key regulator of normal as well as transformed blood cells, and APL is driven by fusion genes involving retinoic acid receptors, primarily RARA. Besides, RARA breakpoints are highly fixed in variant APL, mainly responsible for regulating bone marrow microenvironment and hematopoietic function.